Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,864 | -8,555 | -5,852 | -4,093 | -10,296 |
| Depreciation Amortization | 65 | 407 | 343 | 278 | 214 |
| Accounts receivable | -1,792 | 1,051 | 960 | 691 | -8,729 |
| Other Working Capital | -2,833 | -357 | -1,316 | 81 | -10,176 |
| Other Operating Activity | 2,871 | 17,893 | 17,152 | 17,060 | 26,401 |
| Operating Cash Flow | $-3,553 | $10,439 | $11,287 | $14,017 | $-2,586 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,832 | N/A | N/A | N/A | N/A |
| PPE Investments | -16 | -102 | -85 | -81 | N/A |
| Purchase Of Investment | N/A | -15,422 | N/A | N/A | N/A |
| Investing Cash Flow | $-3,848 | $-15,524 | $-85 | $-81 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 78,135 | 78,135 | 77,030 | N/A |
| Debt Repayment | -10 | -38,097 | -38,080 | -38,057 | -37,985 |
| Common Stock Issued | N/A | 80,104 | 80,104 | 79,069 | 74,878 |
| Common Stock Repurchased | -4,723 | -2,814 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -4,219 | -4,180 | -4,005 | 37,397 |
| Financing Cash Flow | $-4,733 | $113,109 | $115,979 | $114,037 | $74,290 |
| Beginning Cash Position | 112,346 | 4,322 | 4,322 | 4,322 | 4,322 |
| End Cash Position | 100,212 | 112,346 | 131,503 | 132,295 | 76,026 |
| Net Cash Flow | $-12,134 | $108,024 | $127,181 | $127,973 | $71,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,553 | 10,439 | 11,287 | 14,017 | -2,586 |
| Capital Expenditure | -16 | -102 | -85 | -81 | N/A |
| Free Cash Flow | -3,569 | 10,337 | 11,202 | 13,936 | -2,586 |